EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Post-translational modifications in triple-negative breast cancer: research status and translation challenges

Jia-Mei Wang, Yi Zhou, Fei Li, Yu Ding

Cellular Signalling · 2026-10 · 146 · 112696

DOI: 10.1016/j.cellsig.2026.112696 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cellular Signalling, 2026-10. Verfasst von Jia-Mei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departmesystemnt of Plastic Surgery, The Second People's Hospital of Guiyang (Jinyang Hospital)/The Affiliated Jinyang Hospital of Guizhou Medical Un…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Protein Processing, Post-Translational. Die Arbeit nennt 152 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype characterized by the absence of estrogen receptor, progesterone receptor, and HER2 amplification. The lack of therapeutic targets contributes to its poor prognosis and limited treatment options. Nowadays, there is growing evidence that post-translational modifications (PTMs) play important roles in shaping the aggressive nature, immune microenvironment, and metabolic pathways in many tumor types. Here, in this review, we comprehensively summarized the roles of key PTMs, including phosphorylation, ubiquitination, acetylation, protein methylation, SUMOylation, lactylation, glycosylation, β-hydroxybutyrylation, and succinylation in TNBC. We discussed detection technologies for each PTM, detailed their molecular mechanisms and biological functions, and suggested therapeutic strategies targeting these modifications. Moreover, we reviewed PTM crosstalk networks and their clinical implications. Finally, we discussed the translational challenges and propose solutions for developing PTM-based diagnostics and therapies for TNBC. An evidence stratification framework was applied to grade the strength of the reviewed findings, distinguishing mechanistically validated, correlative, and clinically actionable evidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsProtein Processing, Post-TranslationalHumansFemaleTranslational Research, Biomedical

Stichwörter der Autor:innen

BiomarkersMolecular mechanismPost-translational modificationsTriple-negative breast cancer

Autor:innen und Institutionen

  • Departmesystemnt of Plastic Surgery, The Second People's Hospital of Guiyang (Jinyang Hospital)/The Affiliated Jinyang Hospital of Guizhou Medical University, Guiyang 550023, China.
  • Department of Breast Surgery, The People's Hospital of the Qiandongnan Miao And Dong Autonomous Prefecture, Kaili 556000, China.
  • Department of Plastic Surgery, Zhejiang Hospital, Hangzhou 310013, China.
  • Department of Breast and Thyroid, Guiyang Maternal and Child Health Care Hospital, Guiyang 550003, China. Electronic address: 1510980793@qq.com.

Zitieren

APA

Wang, J. M., Zhou, Y., Li, F., & Ding, Y. (2026). Post-translational modifications in triple-negative breast cancer: research status and translation challenges. Cellular Signalling, 146, 112696. https://doi.org/10.1016/j.cellsig.2026.112696

Vancouver

Wang JM, Zhou Y, Li F, Ding Y. Post-translational modifications in triple-negative breast cancer: research status and translation challenges. Cellular Signalling. 2026;146:112696. doi:10.1016/j.cellsig.2026.112696

BibTeX
@article{Wang2026,
  author = {Wang, Jia-Mei and Zhou, Yi and Li, Fei and Ding, Yu},
  title = {Post-translational modifications in triple-negative breast cancer: research status and translation challenges},
  journal = {Cellular Signalling},
  year = {2026},
  volume = {146},
  pages = {112696},
  doi = {10.1016/j.cellsig.2026.112696}
}
Kostenlos starten →